These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7830751)

  • 21. HIV vaccine strategy seeks to woo industry.
    Wadman M
    Nature; 1996 Feb; 379(6567):665. PubMed ID: 8602205
    [No Abstract]   [Full Text] [Related]  

  • 22. NIH officials huddle with AIDS activists.
    Science; 1992 Oct; 258(5080):207. PubMed ID: 1411516
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives. Researchers protest congressional "meddling".
    Kent C
    Faulkner Grays Med Health; 1992 Nov; 46(45):suppl 4 p.. PubMed ID: 10121800
    [No Abstract]   [Full Text] [Related]  

  • 24. Fear of AIDS propels sale of antiviral drugs in Europe.
    Ann Allergy; 1989 May; 62(5):A28. PubMed ID: 2719344
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinton seeks $65 million for States' AIDS drug programs.
    AIDS Policy Law; 1996 Aug; 11(14):3. PubMed ID: 11363679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Reasonable pricing' may be dropped from NIH deals.
    Gavaghan H
    Nature; 1994 Jul; 370(6487):238. PubMed ID: 8035862
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV/AIDS: money matters.
    Roberts L; Jasny B
    Science; 2008 Jul; 321(5888):511. PubMed ID: 18653875
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS drug development. Task force to speed drug pipeline.
    Cohen J
    Science; 1993 Dec; 262(5140):1641. PubMed ID: 8259504
    [No Abstract]   [Full Text] [Related]  

  • 29. Bush declines to support drug companies' line on AIDS profits.
    Dickson D
    Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
    [No Abstract]   [Full Text] [Related]  

  • 30. No green light yet. A long-awaited report supports medical marijuana. So now what?
    Kalb C
    Newsweek; 1999 Mar; 133(13):35. PubMed ID: 10346464
    [No Abstract]   [Full Text] [Related]  

  • 31. The scientific agenda for AIDS.
    Fauci AS
    Issues Sci Technol; 1988; 4(2):33-42. PubMed ID: 10287932
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS office budget morass settled.
    Science; 1996 Mar; 271(5253):1221. PubMed ID: 8638095
    [No Abstract]   [Full Text] [Related]  

  • 33. Battle looms over NIH AIDS office.
    Science; 1994 May; 264(5161):895. PubMed ID: 8178145
    [No Abstract]   [Full Text] [Related]  

  • 34. Health secretary backs AIDS office's budget authority.
    Wadman M
    Nature; 1996 Feb; 379(6566):570. PubMed ID: 8628379
    [No Abstract]   [Full Text] [Related]  

  • 35. New AIDS programs may improve system.
    Am Fam Physician; 1989 Jan; 39(1):23-4. PubMed ID: 2911957
    [No Abstract]   [Full Text] [Related]  

  • 36. Perspectives. AIDS: where are we going?
    Sorian R
    Med Health (1989); 1989 Nov; 43(44):suppl 4 p.. PubMed ID: 10295783
    [No Abstract]   [Full Text] [Related]  

  • 37. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS task force fizzles out.
    Cohen J
    Science; 1996 Jan; 271(5248):438-9. PubMed ID: 8560249
    [No Abstract]   [Full Text] [Related]  

  • 39. Promising AIDS drug looking for a sponsor.
    Palca J
    Science; 1991 Jul; 253(5017):262-3. PubMed ID: 1857962
    [No Abstract]   [Full Text] [Related]  

  • 40. NIH plans to begin AIDS drug trials at earlier stage.
    Macilwain C
    Nature; 1993 Apr; 362(6419):382. PubMed ID: 8464459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.